PAR DRUGS AND CHEMICALS
Back to All Ratios
|
PAR DRUGS AND CHEMICALS Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 6.15 | 14.78 | 11.83 | 15.73 | 5.28 |
What is the latest Price to Cash Earnings (PCE) ratio of PAR DRUGS AND CHEMICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 6.15 |
| Mar2024 | 14.78 |
| Mar2023 | 11.83 |
| Mar2022 | 15.73 |
| Mar2021 | 5.28 |
How is Price to Cash Earnings (PCE) of PAR DRUGS AND CHEMICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 6.15 | -58.39 | |
| Mar2024 | 14.78 | 24.94 | |
| Mar2023 | 11.83 | -24.79 | |
| Mar2022 | 15.73 | 197.92 | |
| Mar2021 | 5.28 | - | |
Other Financial Ratios of PAR DRUGS AND CHEMICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of PAR DRUGS AND CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PAR DRUGS AND CHEMICALS | ₹152.5 Cr | -5.7% | -11.8% | 16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | -5.7% |
-11.8% |
16.7% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses